Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapyMaus, M K H ; Hanna, D L ; Stephens, C L ; Astrow, S H ; Yang, D ; Grimminger, P P ; Loupakis, F ; Hsiang, J H ; Zeger, G ; Wakatsuki, T ; Barzi, A ; Lenz, H-JThe pharmacogenomics journal, 2015-08, Vol.15 (4), p.354-362 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Disparities in the Radiation Treatment Time and Outcome of Anal Cancer in Public and Private Hospital PatientsYoo, S.K ; Guan, J ; Ahmed, A.A ; Barzi, A ; Song, SInternational journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E179-E179 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for regorafenib in refractory metastatic colorectal cancer (mCRC) – An ACCRU Network studyBekaii-Saab, T. ; Ou, F. ; Anderson, D. ; Ahn, D. ; Boland, P. ; Ciombor, K. ; Jacobs, N. ; Desnoyers, R. ; Cleary, J. ; Meyers, J. ; Chiorean, E. ; Pedersen, K. ; Barzi, A. ; Sloan, J. ; McCune, J. ; Lacouture, M. ; Lenz, H. ; Grothey, A.Annals of oncology, 2018-06, Vol.29, p.v105-v105 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancerSuenaga, M. ; Schirripa, M. ; Cao, S. ; Zhang, W. ; Yang, D. ; Murgioni, S. ; Rossini, D. ; Marmorino, F. ; Mennitto, A. ; Ning, Y. ; Okazaki, S. ; Berger, M.D. ; Miyamoto, Y. ; Gopez, R. ; Barzi, A. ; Yamaguchi, T. ; Loupakis, F. ; Lenz, H.-J.Annals of oncology, 2017-05, Vol.28 (5), p.1015-1022 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Comparative effectiveness of initiating colorectal cancer (CRC) screening (scr) at age 45Barzi, A ; Siegel, R ; Fedewa, S ; Lenz, H.J ; Quinn, D ; Jemal, A ; Sadeghi, SEuropean journal of cancer (1990), 2017-02, Vol.72, p.S157-S157 [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Comparative Effectiveness of Panitumumab Versus Cetuximab In Patients With Chemo-Refractory Wild-Type Kras Metastatic Colorectal CancerXu, Y ; Hay, J.W ; Barzi, AValue in health, 2016-05, Vol.19 (3), p.A2-A2 [Periódico revisado por pares]Texto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinicsAhn, D. ; Barzi, A. ; Miksad, R.A. ; Surinach, A. ; Corvino, F.A. ; Valderrama, A. ; Mamlouk, K. ; Pulgar, S. ; Bekaii-Saab, T.Annals of oncology, 2018-10, Vol.29, p.viii251-viii251 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancerSunakawa, Y. ; Stremitzer, S. ; Cao, S. ; Zhang, W. ; Yang, D. ; Wakatsuki, T. ; Ning, Y. ; Yamauchi, S. ; Stintzing, S. ; Sebio, A. ; El-khoueiry, R. ; Matsusaka, S. ; Parekh, A. ; Barzi, A. ; Azuma, M. ; Watanabe, M. ; Koizumi, W. ; Lenz, H.-J.Annals of oncology, 2015-02, Vol.26 (2), p.332-339 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastasesStremitzer, S. ; Zhang, W. ; Yang, D. ; Ning, Y. ; Stintzing, S. ; Sunakawa, Y. ; Sebio, A. ; Yamauchi, S. ; Matsusaka, S. ; Parekh, A. ; Barzi, A. ; El-Khoueiry, R. ; Stift, J. ; Wrba, F. ; Gruenberger, T. ; Lenz, H.-J.Annals of oncology, 2015-08, Vol.26 (8), p.1728-1733 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trialsSebio, A ; Stintzing, S ; Heinemann, V ; Sunakawa, Y ; Zhang, W ; Ichikawa, W ; Tsuji, A ; Takahashi, T ; Parek, A ; Yang, D ; Cao, S ; Ning, Y ; Stremitzer, S ; Matsusaka, S ; Okazaki, S ; Barzi, A ; Berger, M D ; Lenz, H-JThe pharmacogenomics journal, 2018-01, Vol.18 (1), p.43-48 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |